Naari Pharma is a finished-dose manufacturer based in India. It appears in 7 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with JFDA (JO), NAFDAC (NG) and BOMRA (BW). Its GMP standing is certified by NAFDAC (NG), CDSCO (India) and EMA. Customs aggregates show $13.0M of exports covering 267 molecules to 50 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Uttarakhand, United Arab Emirates | Not on file |
| Rudrapur, India | 3014247908 |
| dist udham singh nagar, India | Not on file |
| Dist.-Udham Singh Nagar, India | Not on file |
| Udham Singh Nagar, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| JFDA (JO) | 5 | None |
| NAFDAC (NG) | 1 | 2 |
| BOMRA (BW) | 1 | None |
| CDSCO (India) | None | 2 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.5M | 21 |
| 2025 | Not reported | $13.0M | 50 |
| 2024 | Not reported | $14.5M | 53 |
| 2023 | Not reported | $11.6M | 42 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Naari Pharma comes back tiered against every other supplier able to file there.
Start for free